EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development

Thiago Jordão da Silva Lemos iD, Herbert Guimarães de Sousa Silva, José Osvaldo Previato, Lucia Mendonça-Previato iD, Elisangela Oliveira de Freitas, Angela Silva Barbosa iD, Marcia Regina Franzolin iD, Luis Fernando Dos Santos iD, Bruna de Sousa Melo, Geovana Ferreira Dos Anjos, Renata Hiromi Nakagima Gonçalves, Marta de Oliveira Domingos

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Thiago Jordão da Silva Lemos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo 05503-900, SP, Brazil. Hauptthemen laut MEDLINE: Enteropathogenic Escherichia coli, Enterohemorrhagic Escherichia coli, Escherichia coli Infections, Escherichia coli Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP, Fundação Butantan, São Paulo, SP, Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enteropathogenic Escherichia coli (EPEC) produce a capsule of polysaccharides identical to those composing the O-antigen polysaccharide of its LPS (lipopolysaccharide) molecules. In light of this, the impact of O26 polysaccharides on the immune evasion mechanisms of capsulated O26 EPEC compared to non-capsulated enterohemorrhagic Escherichia coli (EHEC) was investigated. Our findings reveal that there was no significant difference between the levels in EPEC and EHEC of rhamnose (2.8:2.5), a molecule considered to be a PAMP (Pathogen Associated Molecular Patterns). However, the levels of glucose (10:1.69), heptose (3.6:0.89) and N-acetylglucosamine (4.5:2.10), were significantly higher in EPEC than EHEC, respectively. It was also observed that the presence of a capsule in EPEC inhibited the deposition of C3b on the bacterial surface and protected the pathogen against lysis by the complement system. In addition, the presence of a capsule also protected EPEC against phagocytosis by macrophages. However, the immune evasion provided by the capsule was overcome in the presence of anti-O26 polysaccharide antibodies, and additionally, these antibodies were able to inhibit O26 EPEC adhesion to human epithelial cells. Finally, the results indicate that O26 polysaccharides can generate an effective humoral immune response, making them promising antigens for the development of a vaccine against capsulated O26 E. coli.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enteropathogenic Escherichia coliEnterohemorrhagic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHumansImmune EvasionLipopolysaccharidesVaccine Development

Stichwörter der Autor:innen

E. coli O26EHECEPECenterohemorrhagic E. colienteropathogenic E. colivaccine

Substanzen

Escherichia coli ProteinsLipopolysaccharides

Autor:innen und Institutionen

  • Laboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo 05503-900, SP, Brazil.
  • Instituto de Biofísica Carlos Chagas Filho, UFRJ, Avenida Carlos Chagas Filho, 373, Cidade Universitária, Rio de Janeiro 21941-902, RJ, Brazil.
  • Centro de Bacteriologia, Núcleo de Doenças Entéricas, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 355, São Paulo 01246-000, SP, Brazil.

ORCID-Profile: Thiago Jordão da Silva Lemos, Lucia Mendonça-Previato, Angela Silva Barbosa, Marcia Regina Franzolin, Luis Fernando Dos Santos

Förderung

  • FAPESP
  • Fundação Butantan, São Paulo, SP, Brazil

Zitieren

APA

Lemos, T. J. D. S., Silva, H. G. S., Previato, J. O., Mendonça-Previato, L., Freitas, E. O., Barbosa, A. S., Franzolin, M. R., Santos, L. F. D., Melo, B. S., Anjos, G. F. D., Gonçalves, R. H. N., & Domingos, M. O. (2024). O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052878

Vancouver

Lemos TJDS, Silva HGS, Previato JO, Mendonça-Previato L, Freitas EO, Barbosa AS, et al. O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052878

BibTeX
@article{Lemos2024,
  author = {Lemos, Thiago Jordão da Silva and Silva, Herbert Guimarães de Sousa and Previato, José Osvaldo and Mendonça-Previato, Lucia and Freitas, Elisangela Oliveira de and Barbosa, Angela Silva and Franzolin, Marcia Regina and Santos, Luis Fernando Dos and Melo, Bruna de Sousa and Anjos, Geovana Ferreira Dos and Gonçalves, Renata Hiromi Nakagima and Domingos, Marta de Oliveira},
  title = {O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052878}
}
Kostenlos starten →